|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
2/20/20 Assertio Therapeutics, Inc. 8-K:1,2,8,9 2/13/20 3:561K Toppan Merrill/FA
12/20/11 Assertio Therapeutics, Inc. 8-K:1,5 12/15/11 1:26K Toppan Merrill/FA
8/22/11 Assertio Therapeutics, Inc. 8-K:1 8/22/11 1:33K Toppan Merrill/FA
4/6/11 Assertio Therapeutics, Inc. 8-K:1,5 4/1/11 1:32K Toppan Merrill/FA
3/16/11 Assertio Therapeutics, Inc. 8-K:1,8 3/15/11 1:23K Toppan Merrill/FA
11/2/07 Assertio Therapeutics, Inc. 8-K:1 10/29/07 1:24K Toppan Merrill/FA
7/5/07 Assertio Therapeutics, Inc. 8-K:1 7/5/07 1:22K Toppan Merrill/FA
6/29/05 Assertio Therapeutics, Inc. 8-K:1,9 6/24/05 2:149K Toppan Merrill/FA
____________ | ¹ | Filing/Form Type: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. |
|